The global gene editing tool market size surpassed USD 693 million in 2024 and is predicted to reach around USD 3,784 million by 2034, registering a CAGR of 18.5% from 2024 to 2034.
The gene editing market refers to the process of modifying the DNA which involves adding, removing, or altering specific segments of DNA. Gene editing technology is the most effective way to analyze gene function, and pathophysiology of disorders, create new gene therapeutic targets, breed varieties of crops, and perform life science-related tasks. The increasing prevalence of genetic abnormalities is fueling the market for gene editing tools. The use of technologies such as CRISPR-Cas9, TALENs, and zinc finger nucleases, are widely used and available creating new opportunities for the treatment of genetic abnormalities. Moreover, it's also used in agriculture sectors to improve crop quality, increase nutritional value, and longer shelf life.
Furthermore, the rising demand from the healthcare sector as gene editing can replace mutated genes responsible for several diseases endures conditions such as sickle cell anemia, cystic fibrosis, and muscular dystrophy. Also, the increasing demand for personalized medicines and advancements in technology propel the market for gene editing tools. Many healthcare professionals are prescribing medications according to the patient's genetic makeup which offers better patient outcomes fueling the market for gene editing tools.
Published by Ajit Bansod
